🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with coronary artery calcium score changes on glp-1? Page 6

Has anyone dealt with coronary artery calcium score changes on glp-1?

KarenAZ_mom Thu, Apr 4, 2024 at 11:16 PM 35 replies 2,233 viewsPage 6 of 7
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Apr 8, 2024 at 11:40 PM#26

From the other side of the consultation, briefly.

I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

16 months later: down 43 lbs, off atorvastatin, A1C from 8.6% to 5.2%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

21 19MeganSA_TX, LarryQC_SD, wanda_boise and 18 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Apr 9, 2024 at 10:22 AM#27
traveltech_sara said:
I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Same pattern here, and in the same order.

Last edited: Apr 9, 2024 at 12:22 PM
22 20SleepFixSam, PurityPaulOR, MaxMetOK and 19 others
Reply Quote Save Share Report
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Apr 9, 2024 at 9:04 PM#28
traveltech_sara said:
I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my key markers:

Weight: consistent downtrend, -1.5 lbs/week average
Fasting glucose (finger stick): stable at 84 mg/dL
Blood pressure (home): 115/74 average
Resting heart rate: 64 bpm (down from 80)
Waist circumference: down 14 inches total

The resting heart rate improvement correlates with cardiovascular fitness gains. Everything is moving in the right direction.

23 21Admin, Dr.Martinez, mike_mod and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Apr 10, 2024 at 7:46 AM#29
traveltech_sara said:
I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

I want to bring up the cardiovascular angle on cardiovascular risk.

The SELECT trial demonstrated a 20% reduction in MACE with semaglutide 2.4mg[1]. This is practice-changing because the CV benefit appears to be independent of the degree of weight loss — suggesting direct vascular and anti-inflammatory mechanisms.

For cardiovascular risk, this means we need to think beyond the primary outcome and consider the cardiovascular implications. The all-cause mortality reduction (HR 0.81) is the most clinically meaningful signal.

References:
[1] Lincoff AM, et al. N Engl J Med. 2023;389(24):2221-2232.
24 22andrew_nyc, Dr.EndoEP, GraceAZ_72 and 21 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Apr 10, 2024 at 6:28 PM#30
pete_RVA said:
Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my…

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

46 19HPLC_Greg, LibrarianMeg, bri_stats and 43 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register